| AA | Amino acid |
| ALP | Alkaline phosphatase |
| Ang | Angiotensin |
| AP-1 | Activator protein-1 |
| ASCs | Adipose-stromal cells |
| CAD | Coronary artery disease |
| CIMT | Carotid intima-media thickness |
| CKD | Chronic kidney disease |
| CVD | Cardiovascular disease; |
| DR | Death receptors; |
| EC | Endothelial cell; |
| ECFC | Endothelial colony-forming cell; |
| EndMT | Endothelial to mesenchymal transition |
| EPC | Endothelial progenitor cell |
| FA | Fatty acid |
| FAO | Fatty acid–beta-oxidation |
| FGFs | Fibroblast growth factors |
| GDF-11 | Growth differentiation factor-11 |
| GFR | Glomerular Filtration Rate |
| GLUT | Glucose transporter |
| HDL | High Density Lipoproteins |
| HSPGs | Heparan sulfate proteoglycans |
| ICAM | Intercellular adhesion molecule |
| IL | Interleukin |
| kD | kiloDalton |
| MMP | Matrix metalloprotease |
| Nf-κB | Nuclear factor κB |
| NO | Nitric oxide |
| NOS | NO synthetase |
| NOX | NADPH oxidase |
| Nrf2 | Nuclear factor-E2-related factor 2 |
| OCIF | Osteoclastogenesis inhibitory factor |
| OPG | Osteoprotegerin |
| OxLDL | Oxidized low density lipoprotein |
| PPARs | Peroxisome proliferator-activated receptors |
| RA | Rheumatoid arthritis |
| RANK | Receptor activator of nuclear factor κ B |
| RANKL | Receptor activator of nuclear factor κ B ligand |
| ROS | Reactive oxygen species |
| SMPC | Smooth muscle progenitor cells |
| TGF | Transforming growth factor |
| TNF | Tumor necrosis factor |
| TNFR | Tumor necrosis factor receptor |
| TNFRS | Tumor necrosis factor receptor superfamily |
| TRAF | TNFR-associated factor |
| TRAIL | Tumor necrosis factor-related apoptosis-inducing ligand |
| TSP-1 | Thrombospondin-1 |
| VCAM | Vascular adhesion molecule |
| VEGF | Vascular endothelial growth factor |
| VSMC | Vascular smooth muscle cells |
| vWF | von Willebrand factor |
| WPB | Weibel-Palade bodies |